Dear Sir, We have Publsihed our Outcome of Mar-26 Results as requred under Regulation 47(3) of SEBI(LODR), Regulations,2015 in 1) FREE PRESS JOURNAL 2) NAV SHAKTI on 30-4-2026. Kindly ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Colinz Laboratories Ltd has published its audited financial results for Q4 FY26 and the full year ended March 31, 2026. For Q4, revenue increased to Rs. 192.24 lakh (up 25.9% YoY from Rs. 152.70 lakh), with net profit after tax of Rs. 17.12 lakh (up from Rs. 15.04 lakh in Q4 FY25). For the full year FY26, revenue was Rs. 662.05 lakh (down 3% from Rs. 682.56 lakh in FY25), but net profit after tax improved to Rs. 51.45 lakh (up from Rs. 49.66 lakh). Earnings per share stood at Rs. 0.68 (basic and diluted, not annualized). The statutory auditors issued an unqualified audit report, and the results were approved by the Board on April 29, 2026.
The company showed improved profitability despite lower full-year revenue, indicating better cost management. Strong Q4 performance may positively influence investor sentiment, though the small company size (market cap context) should be considered.